Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Ocular Therapeutix, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||
| Equity | Common Stock, $0.0001 par value per share | Other | 1,250,000 shares (2) | $ | 10.76 | (3) | $ | 13,450,000 | (3) | $153.10 per $1,000,000 | $ | 2,059.20 | ||||||||
| Total Offering Amounts | $ | 13,450,000 | $ | 2,059.20 | ||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||
| Net Fee Due | $ | 2,059.20 | ||||||||||||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (2) | Consists of 1,250,000 shares issuable under the 2019 Inducement Stock Incentive Plan, as amended. |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of the average of the high and low sale prices of the registrant’s common stock on the Nasdaq Global Market on November 12, 2024, in accordance with Rule 457(c) under the Securities Act. |
